Scale-Up Filter Capsules
Pharmaco Global’s scale-up filter capsules for pharmaceutical manufacturing are single-use depth filtration units designed to support the clarification and polishing of biological and pharmaceutical process fluids across the full range of manufacturing scales. These pharmaceutical scale-up filtration capsules ensure consistent performance from development through to commercial production.
By maintaining a consistent media composition, lenticular geometry, and capsule design across all available filtration-area configurations, these units allow filtration parameters established during development to be carried over into full-scale manufacturing without the need to recharacterise or revalidate the filtration step. This reduces process variability, accelerates scale-up timelines, and supports validated, GMP-compliant production.
The scale-up capsule is engineered for secondary polishing and intermediate clarification in the manufacture of biologics, including recombinant proteins and monoclonal antibodies, across process volumes ranging from sub-litre laboratory runs through to large-scale commercial production.
Related products
Frequently Asked Questions
Scale-up filter capsules are single-use, closed filtration units with progressively larger membrane surface areas — from 25 cm² (lab) through 170 cm² and 340 cm² (pilot) to 1020 cm²+ (production scale). They enable direct filtration scale-up using identical materials and lenticular design — without requalification or membrane revalidation between scales.
Scale-up capsule filters eliminate cleaning validation, CIP requirements, and cross-contamination risk between batches. Identical materials across all size formats enable direct scale-up without membrane revalidation — significantly reducing development timelines and regulatory burden. Closed single-use design also minimises operator drug product exposure during filter installation and changeout.
Maintain constant flux (L/m²/h) and transmembrane pressure across scales. If a 25 cm² capsule processes 1 L, a 1020 cm² capsule processes approximately 40 L under identical conditions. Capsule manufacturers provide scale-up calculators and small-scale filterability study protocols to accurately predict production-scale performance before committing to manufacturing batches.
Scale-up capsule filters are used for sterilising filtration of bulk APIs and biologics, bioburden reduction, cell culture harvest clarification, buffer and media filtration, and gas filtration — spanning early clinical batch manufacturing through full commercial production. They are used across both small molecule pharmaceutical and large molecule biopharmaceutical manufacturing.
Scale-up capsule filters span 25 cm² (lab screening), 170 cm² (early scale-up), 340 cm² (pilot), and 1020 cm² (small production batches). Larger multi-element encapsulated systems extend capacity to process 25,000+ L per campaign — using the same validated membrane format consistently across all development and commercial manufacturing stages.
PUPSIT (Pre-Use Post-Sterilisation Integrity Test) is required by EU GMP Annex 1 (2022) for sterilising-grade filters in aseptic manufacturing. Scale-up capsule filters used for sterilising filtration must be integrity-tested post-sterilisation and before product contact — confirming membrane integrity was maintained through the sterilisation cycle before drug product filtration begins.
Validation includes: drug product compatibility testing measuring extractables and potency impact; bacterial retention validation using B. diminuta at ≥10⁷ CFU/cm² per FDA guidance; integrity test correlation establishing bubble point and forward-flow limits; and extractables/leachables testing per USP <87>/<88> and ICH Q3D — all documented for IND, NDA, BLA, and MAA submissions.
Scale-up capsule filters are supported by FDA Drug Master Files (DMFs), lot-specific Certificates of Quality, USP <88> Class VI biocompatibility compliance, extractables data packages, bacterial retention validation guides, and integrity test acceptance criteria — the full regulatory documentation package required for global pharmaceutical regulatory submissions to FDA, EMA, PMDA, and Health Canada.
Yes, all our products are designed and sourced to meet international regulatory standards, including GMP, USFDA, EU-GMP, WHO, and other relevant compliance requirements.
Absolutely. Our solutions are engineered for seamless integration with existing systems, ensuring minimal disruption and optimal performance within your current setup.
Yes, our team offers technical consultation to help you choose the most suitable product based on your process requirements, facility design, and compliance needs.
Yes, all our products are aligned with our turnkey execution approach, ensuring compatibility with overall facility design, engineering, and operational requirements.
Yes, we provide customised solutions tailored to your process, capacity, and regulatory requirements to ensure optimal performance and efficiency.
Our products are used across pharmaceutical manufacturing, biotechnology, nutraceuticals, research laboratories, and regulated healthcare environments.
We follow strict quality standards and work with trusted technologies and manufacturing processes to ensure consistent performance, durability, and compliance.
Yes, we offer ongoing technical support to ensure smooth operation, performance optimisation, and long-term reliability of all supplied systems and components.
